Self-sampling blood collection device market seen reaching $1.79 billion by 2030

The self-sampling blood collection and storage device market is forecast to grow from $1.08 billion in 2026 to $1.79 billion by 2030, driven by at-home healthcare demand, telemedicine, and advances in fingerstick and micro-needle tools. North America is expected to lead in 2025, while Asia-Pacific is projected to post the fastest growth.

Why it matters: - Self-sampling blood collection and storage devices are becoming part of a broader shift toward home-based care, remote diagnostics, and easier access to testing. - The market's growth signals rising demand for convenient blood collection tools that reduce clinic visits and support monitoring for chronic disease, genetic testing, and infectious disease testing. - The report also points to a larger commercial opportunity for companies building digital health platforms, preservation reagents, and user-friendly at-home diagnostic products.

What happened: - The Business Research Company published a 2026 market report on the global self-sampling blood collection and storage device market. - The market is projected to increase from $0.95 billion in 2025 to $1.08 billion in 2026. - The report forecasts the market will reach $1.79 billion by 2030. - The report covers market size, trends, global forecast data and regional dynamics through 2035. - The company made a free sample and the full report available online as a free sample and the full market report.

The details: - The market's 2025-2026 growth reflects a 13.8% CAGR. - The 2026-2030 forecast implies a 13.5% CAGR. - Historical growth was driven by limited availability of self-sampling devices, dependence on clinical visits for blood collection, growing awareness of home diagnostic options, rising chronic disease rates, and the launch of basic blood collection kits. - The report says future growth will be driven by micro-needle and fingerstick innovation, wider use of personalized healthcare, telemedicine and remote patient monitoring, higher demand for genetic and drug testing, and integrated digital health platforms. - Key trends include more at-home blood collection, stronger demand for remote diagnostics, better stabilization and preservation reagents, broader genetic and infectious disease testing, and improved safety and ease of use. - Self-sampling devices are designed to let people collect their own blood safely and easily, usually through fingerstick or micro-needle technology. - The devices collect, stabilize, and preserve small blood volumes for lab testing and help reduce reliance on clinical visits. - The market report says North America is expected to hold the largest share in 2025. - The Asia-Pacific region is projected to grow fastest over the forecast period. - Other regions covered in the report include South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

Between the lines: - The market forecast reflects a consumer shift toward healthcare that is more convenient, remote, and less tied to traditional clinics. - The mention of home- and community-based care employment highlights the expanding infrastructure around non-clinic health services. - Bureau of Labor Statistics data cited in the release showed U.S. home- and community-based care reached 4.3 million jobs in July 2024. - The release links much of the growth case to technologies that make at-home sampling more reliable, which suggests competition may increasingly center on sample quality, safety, and integration with digital workflows.

What's next: - The market is expected to keep expanding through 2030 as home testing, telemedicine, and remote monitoring become more common. - The Business Research Company says its 2026 reports now include market attractiveness scoring, TAM analysis, company scoring matrix graphics, Excel-based dashboards, market hotspots infographics, and updated technology and trend analysis. - Regional competition will likely remain centered on North America and the Asia-Pacific region as adoption broadens.

The bottom line: - Self-sampling blood collection is moving from a niche convenience to a core part of remote healthcare, and the market data points to sustained double-digit growth over the next several years.